UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 206

Sortiert nach

1023-91 Relationship between [beta]-adrenergic system polymorphisms and coronary peak flow velocity ratio in women: Analysis from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A253

2004

Volltextzugriff (PDF)

1023-91 Relationship between β-adrenergic system polymorphisms and coronary peak flow velocity ratio in women: Analysis from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A253-A253

2004

Volltextzugriff (PDF)

1027-193 Influence of genetic and nongenetic factors on endothelium-dependent microvascular reactivity in the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A452-A452

2004

Volltextzugriff (PDF)

3D printing of alginate/thymoquinone/halloysite nanotube bio-scaffolds for cartilage repairs: experimental and numerical study

Medical & biological engineering & computing, 2022-11, Vol.60 (11), p.3069-3080

2022

Volltextzugriff (PDF)

Abstract 2321: CXCL5 Genotype is Associated with Mortality after Acute Coronary Syndromes

Circulation (New York, N.Y.), 2007-10, Vol.116 (suppl_16)

2007

Volltextzugriff (PDF)

Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation

Journal of translational medicine, 2008-03, Vol.6 (1), p.11-11, Article 11

2008

Volltextzugriff (PDF)

Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project

Archives of internal medicine (1960), 2009-05, Vol.169 (9), p.843

2009

Volltextzugriff (PDF)

Allopurinol pharmacogenetics: assessment of potential clinical usefulness

Pharmacogenomics, 2011-12, Vol.12 (12), p.1741-1749

2011

Volltextzugriff (PDF)

Angiotensin system polymorphisms and traditional risk factors as predictors of heart failure prognosis

Clinical pharmacology and therapeutics, 2005-02, Vol.77 (2), p.P63-P63

2005

Volltextzugriff (PDF)

Assessment of glycated hemoglobin using A1CNow+ point-of-care device as compared to central laboratory testing

Journal of diabetes science and technology, 2008-09, Vol.2 (5), p.822-828

2008

Volltextzugriff (PDF)

Association of partial systemic exposure and abuse potential for opioid analgesics with abuse deterrence labeling claims supporting product-specific guidance

EClinicalMedicine, 2021-11, Vol.41, p.101135-101135, Article 101135

2021

Volltextzugriff (PDF)

Atorvastatin Effect on Circulating and Leukocyte-Produced CD40 Ligand Concentrations in People with Normal Cholesterol Levels: A Pilot Study

Pharmacotherapy, 2006-11, Vol.26 (11), p.1572-1577

2006

Volltextzugriff (PDF)

Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs

The pharmacogenomics journal, 2004-12, Vol.4 (6), p.354-358

2004

Volltextzugriff (PDF)

β -Adrenergic Receptor Polymorphisms and Antihypertensive Response to Metoprolol

Clinical pharmacology and therapeutics, 2003-07, Vol.74 (1), p.44-52

2003

Volltextzugriff (PDF)

Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol

Clinical pharmacology and therapeutics, 2003-07, Vol.74 (1), p.44-52

2003

Volltextzugriff (PDF)

Beta-1 adrenoreceptor gene haplotypes and antihypertensive response to Beta-blocker therapy

Clinical pharmacology and therapeutics, 2003-02, Vol.73 (2), p.P97-P97

2003

Volltextzugriff (PDF)

Biomarker Qualification: Toward a Multiple Stakeholder Framework for Biomarker Development, Regulatory Acceptance, and Utilization

Clinical pharmacology and therapeutics, 2015-07, Vol.98 (1), p.34-46

2015

Volltextzugriff (PDF)

Biomarkers in drug development and regulation: a paradigm for clinical implementation of personalized medicine

Biomarkers in medicine, 2011-12, Vol.5 (6), p.705-713

2011

Volltextzugriff (PDF)

Biomarkers to improve the benefit/risk balance for approved therapeutics: a US FDA perspective on personalized medicine

Therapeutic delivery, 2010-11, Vol.1 (5), p.631-641

2010

Volltextzugriff (PDF)

The Biosimilarity Concept: Toward an Integrated Framework for Evidence Assessment

Annals of internal medicine, 2016-10, Vol.165 (8), p.595

2016

Volltextzugriff (PDF)

Blood sampling and the measurement of circulating matrix metalloproteinase-8

Clinica chimica acta, 2008-04, Vol.390 (1), p.158-158

2008

Volltextzugriff (PDF)

Canagliflozin use in patients with renal impairment-Utility of quantitative clinical pharmacology analyses in dose optimization: Journal of Clinical Pharmacology

Journal of clinical pharmacology, 2015-06, Vol.55 (6), p.647-656

2015

Volltextzugriff (PDF)

Canagliflozin use in patients with renal impairment-Utility of quantitative clinical pharmacology analyses in dose optimization

Journal of clinical pharmacology, 2015-06, Vol.55 (6), p.647-656

2015

Volltextzugriff (PDF)

Cancer Pharmacogenomics and Pharmacoepidemiology: Setting a Research Agenda to Accelerate Translation

JNCI : Journal of the National Cancer Institute, 2010-11, Vol.102 (22), p.1698-1705

2010

Volltextzugriff (PDF)

Cardiovascular Pharmacogenomics: Current Status and Future Directions—Report of a National Heart, Lung, and Blood Institute Working Group

Journal of the American Heart Association, 2012-04, Vol.1 (2), p.e000554-n/a

2012

Volltextzugriff (PDF)

1 – 25 von 206

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(193)
Mit Volltextzugriff
(177)

Publikationsform

Sprache

Englisch
(206)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

Science & Technology
(146)
Life Sciences & Biomedicine
(143)
Humans
(110)
Pharmacology & Pharmacy
(95)
Female
(35)
United States
(35)
Biological And Medical Sciences
(33)
Male
(33)
Medical Sciences
(33)
Pharmacogenetics
(33)
Adult
(26)
Middle Aged
(26)
United States Food And Drug Administration
(23)
Pharmacology. Drug Treatments
(20)
Pharmacogenomics
(17)
Genotype
(15)
Aged
(14)
Cardiology. Vascular System
(14)
Cardiovascular System & Cardiology
(14)
Pharmacokinetics
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

1023-91 Relationship between [beta]-adrenergic system polymorphisms and coronary peak flow velocity ratio in women: Analysis from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)

1023-91 Relationship between β-adrenergic system polymorphisms and coronary peak flow velocity ratio in women: Analysis from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)

1027-193 Influence of genetic and nongenetic factors on endothelium-dependent microvascular reactivity in the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)

3D printing of alginate/thymoquinone/halloysite nanotube bio-scaffolds for cartilage repairs: experimental and numerical study

Abstract 2321: CXCL5 Genotype is Associated with Mortality after Acute Coronary Syndromes

Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation

Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project

Allopurinol pharmacogenetics: assessment of potential clinical usefulness

Angiotensin system polymorphisms and traditional risk factors as predictors of heart failure prognosis

Assessment of glycated hemoglobin using A1CNow+ point-of-care device as compared to central laboratory testing

Association of partial systemic exposure and abuse potential for opioid analgesics with abuse deterrence labeling claims supporting product-specific guidance

Atorvastatin Effect on Circulating and Leukocyte-Produced CD40 Ligand Concentrations in People with Normal Cholesterol Levels: A Pilot Study

Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs

β -Adrenergic Receptor Polymorphisms and Antihypertensive Response to Metoprolol

Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol

Beta-1 adrenoreceptor gene haplotypes and antihypertensive response to Beta-blocker therapy

Biomarker Qualification: Toward a Multiple Stakeholder Framework for Biomarker Development, Regulatory Acceptance, and Utilization

Biomarkers in drug development and regulation: a paradigm for clinical implementation of personalized medicine

Biomarkers to improve the benefit/risk balance for approved therapeutics: a US FDA perspective on personalized medicine

The Biosimilarity Concept: Toward an Integrated Framework for Evidence Assessment

Blood sampling and the measurement of circulating matrix metalloproteinase-8

Canagliflozin use in patients with renal impairment-Utility of quantitative clinical pharmacology analyses in dose optimization: Journal of Clinical Pharmacology

Canagliflozin use in patients with renal impairment-Utility of quantitative clinical pharmacology analyses in dose optimization

Cancer Pharmacogenomics and Pharmacoepidemiology: Setting a Research Agenda to Accelerate Translation

Cardiovascular Pharmacogenomics: Current Status and Future Directions—Report of a National Heart, Lung, and Blood Institute Working Group

Suchergebnisse filtern